First Horizon Continues to Grow Its Partnership with Bayer Healthcare
09 Janvier 2006 - 4:27PM
Business Wire
First Horizon Pharmaceutical Corporation ("First Horizon")
(NasdaqNM: FHRX) today announced its growing partnership with Bayer
Healthcare AG ("Bayer"). First Horizon amended its agreement with
Bayer on January 6, 2006, that contemplates a growing partnership
allowing for improved pricing for Federal programs to increase
sales; foreign currency exchange rate protection; and the
opportunity for expanded international distribution rights for
Sular. "We are delighted to announce our continued growing
partnership with Bayer," said Patrick Fourteau, First Horizon's
President and Chief Executive Officer. "This agreement for Sular
plays an important role in allowing First Horizon to grow its
business and service our expanded federal programs emphasis
profitably. We will also be able to look at expanding into
international markets with Bayer's help. " About First Horizon
First Horizon Pharmaceutical Corporation is a specialty
pharmaceutical company that markets, sells and develops
prescription products with a primary focus on cardiology and
women's health. First Horizon has a portfolio that includes 15
branded prescription products of which 8 are actively promoted to
high-prescribing physicians through its recently expanded
nationwide sales force of approximately 525 representatives. First
Horizon's web sit address is: www.fhrx.com. Pease visit First
Horizon's website for full prescribing information on First
Horizon's products.
First Horizon Pharmaceutical (NASDAQ:FHRX)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
First Horizon Pharmaceutical (NASDAQ:FHRX)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about First Horizon Pharmaceutical (MM) (NASDAQ): 0 recent articles
Plus d'articles sur First Horizon Pharmaceutical Corporation